COCO_LATE - Clinical events occurring within 6 months of SARS-COV-2 infection: multicentre cohort

Head :
ROBINEAU Olivier

Last update : 05/06/2021 | Version : 1 | ID : 73902

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Clinical events occurring within 6 months of SARS-COV-2 infection: multicentre cohort
Sign or acronym COCO_LATE
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL MR01, favorable opinion CPP
General Aspects
Medical area Infectious diseases
Psychology and psychiatry
Study in connection with Covid-19 Yes
Scientific investigator(s) (Contact)
Name of the director ROBINEAU
Surname Olivier
Collaborations
Participation in projects, networks and consortia Yes
Funding
Funding status Public
Governance of the database
Sponsor(s) or organisation(s) responsible Tourcoing Hospital
Organisation status Public
Presence of scientific or steering committees Yes
Additional contact
Name of the contact TREHOUX
Surname Solange
Email recherche@ch-tourcoing.fr
Main features
Type of database
Type of database Others
Study databases (details) Cohort study
Database objective
Main objective Describe, over time, the symptoms presented by patients reporting persistent symptoms (more than two months after onset) or onset of symptoms more than 3 weeks after the beginning of symptomatic SARS-CoV-2 (COVID-19) infection evidenced by laboratory tests.
Inclusion criteria 1- History of symptomatic SARS-CoV-2 infection defined by:
A positive RT-PCR result for SARS-CoV-2 OR positive SARS-CoV-2 serology combined with at least one event:
- Anosmia occurring after February 2020
- OR CT scan consistent with COVID-19
- OR ? 2 symptoms coinciding with the virology sample, including: asthenia, cough, dyspnoea, fever, myalgia, dysgeusia, diarrhoea AND not present prior to diagnosis
2- AND persistence of at least one symptom present in the first 3 weeks of COVID-19, more than 8 weeks after the first COVID symptoms
OR late onset of at least one new symptom at least 3 weeks and not more than 6 months after the first symptoms of SARS-CoV-2 infection
3- First symptoms within the past 6 months on the date of inclusion
4- Beneficiary of a health insurance scheme or the state welfare scheme
5- Having signed an informed consent form at inclusion
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology B99-B99 - Other infectious diseases
Gender Male
Woman
Geography area National
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Data
Database activity Current data collection
Type of data collected Clinical data
Paraclinical data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Presence of a biobank Yes
Contents of biobank Serum
Plasma
Procedures
Followed pathology
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here